Many patients suffer not only from respiratory symptoms due to their COVID-19 disease, but also from significantly reduced physical performance. A patent-protected tablet (CICR-NAM) developed at the ...

In high-risk patients with COVID-19, nirmatrelvir/ritonavir treatment shortened the median duration to return to usual health and activities and significantly accelerated the resolution of COVID-19 ...

Yearly Covid-19 Booster Recommendations in Canada, Europe, and Australia. Although the rapid development of multiple Covid-19 vaccines in 2020 represents a major scientific, medical, and regulatory ...

Update: This program has ended and free tests are not current available from the government website. As cases of a new COVID-19 variant tick upward across the U.S., the federal government is again ...

Here’s what we’ve learned – and how our understanding has evolved – since the earliest cases of the novel coronavirus were ...